[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336931-105":59,"doc-detail-336931-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mecom-and-the-prdm-gene-family-in-uterine-endometrial-cancer-bioinformatics-and-experimental-insights-into-pathogenesis-and-therapeutic-potentials","MECOM and the PRDM gene family in uterine endometrial cancer - bioinformatics and experimental insights into pathogenesis and therapeutic potentials","","To elucidate the expression profiles, methylation states, and clinicopathological significance of the PRDM gene family, focusing on the MECOM gene’s role in uterine endometrial cancer (UCEC) and its molecular interactions with the TGFbeta signaling pathway. Methodology combined bioinformatics analyses using UALCAN and GEPIA with in vitro experiments in HEC-1-A cells, including CRISPR-Cas9 editing, CCK-8, flow cytometry, Transwell, and Western blotting. MECOM upregulation was observed in UCEC tissues, with knockout reducing proliferation and migration while increasing apoptosis, whereas overexpression showed opposite effects, affecting TGF-beta pathway proteins. Findings indicate MECOM as a potential therapeutic target for UCEC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mecom-and-the-prdm-gene-family-in-uterine-endometrial-cancer-bioinformatics-and-experimental-insights-into-pathogenesis-and-therapeutic-potentials/336931/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mecom-and-the-prdm-gene-family-in-uterine-endometrial-cancer-bioinformatics-and-experimental-insights-into-pathogenesis-and-therapeutic-potentials/336931.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim regarding the PRDM gene family in uterine endometrial cancer?","Question",{"text":112,"@type":113},"The study examines expression profiles and methylation states of the PRDM gene family, emphasizing MECOM’s role in uterine endometrial cancer and its molecular interaction with the TGFbeta signaling pathway.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were MECOM’s functions tested in the study?",{"text":117,"@type":113},"Bioinformatics analyses were performed using UALCAN and GEPIA, and in vitro experiments in HEC-1-A cells were conducted using CRISPR-Cas9 gene editing and assays such as CCK-8, flow cytometry, and Transwell, with Western blotting to assess TGF-beta pathway protein regulation.",{"name":119,"@type":110,"acceptedAnswer":120},"What phenotypic effects were observed after MECOM knockout or overexpression?",{"text":121,"@type":113},"MECOM knockout reduced cell proliferation and migration while increasing apoptosis; conversely, MECOM overexpression produced reverse effects, consistent with altered regulation of key TGF-beta pathway proteins.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336931,1790196753,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Lou et al. Molecular Medicine (2024) 30:190 [https://doi.org/10.1186/s10020-024-00946-0](https://doi.org/10.1186/s10020-024-00946-0)  \nMolecular Medicine  \n RESEARCH ARTICLE Open Access  \nMECOM and the PRDM gene family   in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials  \nMeng Lou5, Lian Zou1, Liying Zhang2, Yongquan Lu3, Jia Chen1 and Beige Zong4*  \nAbstract  \nTo elucidate the expression profiles, methylation states, and clinicopathological significance of the PRDM gene family, focusing on the MECOM gene’s role in uterine endometrial cancer (UCEC) and its molecular interactions with the TGFbeta signaling pathway. Our methodology combined detailed bioinformatics analyses using UALCAN and GEPIA with in vitro assessments in HEC-1-A cells. Techniques included CRISPR-Cas9 for gene editing and various cellular assays (CCK-8, flow cytometry, Transwell) to evaluate the effects of MECOM on cell proliferation, migration, and apoptosis, alongside Western blot analysis for protein regulation in theTGF-beta pathway. MECOM was upregulated in UCEC tissues, influencing tumor cell behavior significantly. Knockout studies demonstrated reduced proliferation and migration and increased apoptosis, while overexpression showed reverse effects. Mechanistically, MECOM modulated critical proteins within the TGF-beta pathway, impacting cell cycle dynamics and apoptotic processes. The PRDM gene family, particularly MECOM, plays a crucial role in the pathogenesis and progression of UCEC, suggesting its utility as a target for novel therapeutic interventions. Our findings offer valuable insights for future research and potential clinical application in managing uterine endometrial cancer.  \nKeywords PRDM gene family, Uterine endometrial cancer, MECOM, Expression patterns, Methylation status, TGF-beta signaling pathway  \n*Correspondence: Beige Zong [504715943@qq.com](504715943@qq.com)  \n1 Department of Obstetrics and Gynecology, Chongqing Emergency Medical Center, Chongging University Central Hospital, Chongqing 400000, China  \n2 Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Guangxi Medical University, Nanning 530000, China  \n3 Department of Clinical Laboratory, Chongqing Emergency Medical Center, Chongging University Central Hospital, Chongqing 400000, China  \n4 Department of General Surgery, Chongqing Emergency Medical Center, Chongging University Central Hospital, No.1 Jiankang Road, Yuzhong District, Chongqing 400000, China  \n5 Department of Obstetrics and Gynecology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China  \nIntroduction  \nThe incidence of uterine corpus endometrial carcinoma (UCEC), a type of uterine cancer, has been steadily increasing at a rate of approximately 1.3% per year from 2007 to 2016 (Lortet-Tieulent et al. 2018; Pfeiffer et al., 2018; Lheureux et al. 2018; Chiofalo et al. 2020). This rise in incidence can be attributed, in part, to the decreasing fertility rates and the increasing prevalence of obesity (Lortet-Tieulent et al. 2018; Pfeiffer et al., 2018; Lheureux et al. 2018; Chiofalo et al. 2020). Despite significant efforts in diagnosing and treating UCEC, the mortality rate of this cancer has been on the rise over the past decade (Siegel et al. 2020; Oaknin et al. 2022; Kato et al. 2021; Gao et al. 2022). The management of UCEC is  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the ar","cbCaivWCP0P6XSLm","https://ap.wps.com/l/cbCaivWCP0P6XSLm","pdf",6534421,28,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What is the main aim regarding the PRDM gene family in uterine endometrial cancer?\",\"answer\":\"The study examines expression profiles and methylation states of the PRDM gene family, emphasizing MECOM’s role in uterine endometrial cancer and its molecular interaction with the TGFbeta signaling pathway.\"},{\"question\":\"How were MECOM’s functions tested in the study?\",\"answer\":\"Bioinformatics analyses were performed using UALCAN and GEPIA, and in vitro experiments in HEC-1-A cells were conducted using CRISPR-Cas9 gene editing and assays such as CCK-8, flow cytometry, and Transwell, with Western blotting to assess TGF-beta pathway protein regulation.\"},{\"question\":\"What phenotypic effects were observed after MECOM knockout or overexpression?\",\"answer\":\"MECOM knockout reduced cell proliferation and migration while increasing apoptosis; conversely, MECOM overexpression produced reverse effects, consistent with altered regulation of key TGF-beta pathway proteins.\"}]","MECOM and the PRDM gene family in uterine endometrial cancer - bioinformatics and experimental insights into pathogenesis and therapeutic potentials | PDF",1790017111,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0969091e1164e58d71f4deca82bdb20e.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/630c4eb75b8f8542ef29eac906a3fb1d.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd35f925c373eb1c9c9e52cbf80b2720.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6edc2e0c39c54bb66c18f3bf80ce9bc.webp",980,1301]